Francesca Di Bartolomeo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Francesca Di Bartolomeo has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Günther Daum
Institute of Biochemistry, Graz University of Technology, Petersgasse 12/2, 8010 Graz, Austria
4 shared publications - Jens Nielsen
BioInnovation Institute, Copenhagen, Denmark
4 shared publications - Kate Campbell
Department of Biology and Biological Engineering, Chalmers University of Technology, SE-412 96 Gothenburg, Sweden
4 shared publications - Thomas Becker
Institute of Biochemistry and Molecular Biology, University Hospital Bonn, University of Bonn, 53115 Bonn, Germany
3 shared publications Anna Skoczyńska
Department of Epidemiology and Clinical Microbiology, National Medicines Institute (NMI), Warsaw, Poland
2 shared publicationsAriane Wagner
Institute of Biochemistry, Graz University of Technology, Petersgasse 12/2, 8010 Graz, Austria
2 shared publications
Latest Publications
- Open Access
- 16 October 2025
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1623154
Proteomic landscape of imipenem resistance in Pseudomonas aeruginosa: a comparative investigation between clinical and control strains
The increasing prevalence of antimicrobial resistance (AMR) poses a significant challenge to global health, particularly with bacterial pathogens such as Pseudomonas aeruginosa, a notorious cause of nosocomial infections. This study focuses on the comparative proteomic analysis of an imipenem-resistant strain of P. aeruginosa, a representative of world epidemic clone ST235, and a wildtype control strain, P. aeruginosa ATCC 27853, in response to varying concentrations of imipenem. Using label-free quantification (LFQ) and gene ontology (GO) enrichment analyses, we identified significant differences in the proteomic responses between the two strains. The clinical strain exhibited a stable proteomic profile across the imipenem gradient, suggesting pre-established and efficient resistance mechanisms that do not require extensive reconfiguration under antibiotic pressure. In contrast, the control strain showed a broader, more reactive proteomic response, particularly in proteins associated with membrane transport, stress response, and biofilm formation. Notably, uncharacterized proteins were significantly upregulated in the clinical strain, indicating potential novel resistance mechanisms. These findings highlight the distinct strategies employed by the two strains, with the clinical strain’s stable resistance mechanisms contrasting sharply with the control strain’s reactive approach. The study underscores the importance of further research into the uncharacterized proteins that may play crucial roles in antibiotic resistance, potentially leading to new therapeutic targets in the fight against AMR.
- 16 October 2025
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1623154
Open AccessProteomic landscape of imipenem resistance in Pseudomonas aeruginosa: a comparative investigation between clinical and control strains
The increasing prevalence of antimicrobial resistance (AMR) poses a significant challenge to global health, particularly with bacterial pathogens such as Pseudomonas aeruginosa, a notorious cause of nosocomial infections. This study focuses on the comparative proteomic analysis of an imipenem-resistant strain of P. aeruginosa, a representative of world epidemic clone ST235, and a wildtype control strain, P. aeruginosa ATCC 27853, in response to varying concentrations of imipenem. Using label-free quantification (LFQ) and gene ontology (GO) enrichment analyses, we identified significant differences in the proteomic responses between the two strains. The clinical strain exhibited a stable proteomic profile across the imipenem gradient, suggesting pre-established and efficient resistance mechanisms that do not require extensive reconfiguration under antibiotic pressure. In contrast, the control strain showed a broader, more reactive proteomic response, particularly in proteins associated with membrane transport, stress response, and biofilm formation. Notably, uncharacterized proteins were significantly upregulated in the clinical strain, indicating potential novel resistance mechanisms. These findings highlight the distinct strategies employed by the two strains, with the clinical strain’s stable resistance mechanisms contrasting sharply with the control strain’s reactive approach. The study underscores the importance of further research into the uncharacterized proteins that may play crucial roles in antibiotic resistance, potentially leading to new therapeutic targets in the fight against AMR.
- Open Access
Unravelling the Proteomic Landscape of Imipenem Resistance in Pseudomonas aeruginosa : A Comparative Investigation between Clinical and Control Strains
The increasing prevalence of antimicrobial resistance (AMR) poses a significant challenge to global health, particularly with bacterial pathogens such as Pseudomonas aeruginosa , a notorious cause of nosocomial infections. This study focuses on the comparative proteomic analysis of an imipenem-resistant strain of P. aeruginosa , a representative of world epidemic clone ST235, and a wildtype control strain, P. aeruginosa ATCC 27853, in response to varying concentrations of imipenem. Using label-free quantification (LFQ) and gene ontology (GO) enrichment analyses, we identified significant differences in the proteomic responses between the two strains (data available via ProteomeXchange with identifier PXD055744.). The clinical strain exhibited a stable proteomic profile across the imipenem gradient, suggesting pre-established and efficient resistance mechanisms that do not require extensive reconfiguration under antibiotic pressure. In contrast, the control strain showed a broader, more reactive proteomic response, particularly in proteins associated with membrane transport, stress response, and biofilm formation. Notably, uncharacterized proteins were significantly upregulated in the clinical strain, indicating potential novel resistance mechanisms. These findings highlight the distinct strategies employed by the two strains, with the clinical strain’s stable resistance mechanisms contrasting sharply with the control strain’s reactive approach. The study underscores the importance of further research into the uncharacterized proteins that may play crucial roles in antibiotic resistance, potentially leading to new therapeutic targets in the fight against AMR. Highlights: Stable resistance mechanisms : The clinical strain of Pseudomonas aeruginosa (ST235) exhibited a stable proteomic profile across varying concentrations of imipenem, indicating pre-established and efficient resistance mechanisms. Reactive proteomic response : The control strain ( P. aeruginosa ATCC 27853) showed a broader and more reactive proteomic response, particularly in proteins related to membrane transport, stress response, and biofilm formation. Uncharacterized proteins : Significant upregulation of uncharacterized proteins in the clinical strain suggests potential novel resistance mechanisms that warrant further investigation.
Open AccessUnravelling the Proteomic Landscape of Imipenem Resistance in Pseudomonas aeruginosa : A Comparative Investigation between Clinical and Control Strains
The increasing prevalence of antimicrobial resistance (AMR) poses a significant challenge to global health, particularly with bacterial pathogens such as Pseudomonas aeruginosa , a notorious cause of nosocomial infections. This study focuses on the comparative proteomic analysis of an imipenem-resistant strain of P. aeruginosa , a representative of world epidemic clone ST235, and a wildtype control strain, P. aeruginosa ATCC 27853, in response to varying concentrations of imipenem. Using label-free quantification (LFQ) and gene ontology (GO) enrichment analyses, we identified significant differences in the proteomic responses between the two strains (data available via ProteomeXchange with identifier PXD055744.). The clinical strain exhibited a stable proteomic profile across the imipenem gradient, suggesting pre-established and efficient resistance mechanisms that do not require extensive reconfiguration under antibiotic pressure. In contrast, the control strain showed a broader, more reactive proteomic response, particularly in proteins associated with membrane transport, stress response, and biofilm formation. Notably, uncharacterized proteins were significantly upregulated in the clinical strain, indicating potential novel resistance mechanisms. These findings highlight the distinct strategies employed by the two strains, with the clinical strain’s stable resistance mechanisms contrasting sharply with the control strain’s reactive approach. The study underscores the importance of further research into the uncharacterized proteins that may play crucial roles in antibiotic resistance, potentially leading to new therapeutic targets in the fight against AMR. Highlights: Stable resistance mechanisms : The clinical strain of Pseudomonas aeruginosa (ST235) exhibited a stable proteomic profile across varying concentrations of imipenem, indicating pre-established and efficient resistance mechanisms. Reactive proteomic response : The control strain ( P. aeruginosa ATCC 27853) showed a broader and more reactive proteomic response, particularly in proteins related to membrane transport, stress response, and biofilm formation. Uncharacterized proteins : Significant upregulation of uncharacterized proteins in the clinical strain suggests potential novel resistance mechanisms that warrant further investigation.
- Open Access
- 17 August 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (35) , 21804-21812
Proteome reallocation from amino acid biosynthesis to ribosomes enables yeast to grow faster in rich media
Significance: The yeast Saccharomyces cerevisiae is a well-studied organism, which is used as a model organism for studying eukaryal biology and as a cell factory for the production of fuels, chemicals, and pharmaceuticals. For both applications, the way that the cell utilizes its finite protein resource and how those inherent trade-offs manifest themselves is of interest, not least for their impact on cellular metabolism. Here we elucidate how alterations of protein-allocation allow for S. cerevisiae to increase its growth rate. Our results on cellular proteome-allocation may aid the engineering of more efficient strains in industrial biotechnology as well as improve our understanding toward phenotypes of cancer cells that grow faster than normal cells.
- 17 August 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (35) , 21804-21812
Open AccessProteome reallocation from amino acid biosynthesis to ribosomes enables yeast to grow faster in rich media
Significance: The yeast Saccharomyces cerevisiae is a well-studied organism, which is used as a model organism for studying eukaryal biology and as a cell factory for the production of fuels, chemicals, and pharmaceuticals. For both applications, the way that the cell utilizes its finite protein resource and how those inherent trade-offs manifest themselves is of interest, not least for their impact on cellular metabolism. Here we elucidate how alterations of protein-allocation allow for S. cerevisiae to increase its growth rate. Our results on cellular proteome-allocation may aid the engineering of more efficient strains in industrial biotechnology as well as improve our understanding toward phenotypes of cancer cells that grow faster than normal cells.
- 25 March 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (14) , 7575-7583
Building blocks are synthesized on demand during the yeast cell cycle
For cells to replicate, a sufficient supply of biosynthetic precursors is needed, necessitating the concerted action of metabolism and protein synthesis during progressive phases of cell division. A global understanding of which biosynthetic processes are involved and how they are temporally regulated during replication is, however, currently lacking. Here, quantitative multiomics analysis is used to generate a holistic view of the eukaryal cell cycle, using the budding yeast Saccharomyces cerevisiae . Protein synthesis and central carbon pathways such as glycolysis and amino acid metabolism are shown to synchronize their respective abundance profiles with division, with pathway-specific changes in metabolite abundance also being reflected by a relative increase in mitochondrial volume, as shown by quantitative fluorescence microscopy. These results show biosynthetic precursor production to be temporally regulated to meet phase-specific demands of eukaryal cell division.
- 25 March 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (14) , 7575-7583
Building blocks are synthesized on demand during the yeast cell cycle
For cells to replicate, a sufficient supply of biosynthetic precursors is needed, necessitating the concerted action of metabolism and protein synthesis during progressive phases of cell division. A global understanding of which biosynthetic processes are involved and how they are temporally regulated during replication is, however, currently lacking. Here, quantitative multiomics analysis is used to generate a holistic view of the eukaryal cell cycle, using the budding yeast Saccharomyces cerevisiae . Protein synthesis and central carbon pathways such as glycolysis and amino acid metabolism are shown to synchronize their respective abundance profiles with division, with pathway-specific changes in metabolite abundance also being reflected by a relative increase in mitochondrial volume, as shown by quantitative fluorescence microscopy. These results show biosynthetic precursor production to be temporally regulated to meet phase-specific demands of eukaryal cell division.
- Open Access
- 17 March 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (13) , 7524-7535
Absolute yeast mitochondrial proteome quantification reveals trade-off between biosynthesis and energy generation during diauxic shift
Saccharomyces cerevisiae constitutes a popular eukaryal model for research on mitochondrial physiology. Being Crabtree-positive, this yeast has evolved the ability to ferment glucose to ethanol and respire ethanol once glucose is consumed. Its transition phase from fermentative to respiratory metabolism, known as the diauxic shift, is reflected by dramatic rearrangements of mitochondrial function and structure. To date, the metabolic adaptations that occur during the diauxic shift have not been fully characterized at the organelle level. In this study, the absolute proteome of mitochondria was quantified alongside precise parametrization of biophysical properties associated with the mitochondrial network using state-of-the-art optical-imaging techniques. This allowed the determination of absolute protein abundances at a subcellular level. By tracking the transformation of mitochondrial mass and volume, alongside changes in the absolute mitochondrial proteome allocation, we could quantify how mitochondria balance their dual role as a biosynthetic hub as well as a center for cellular respiration. Furthermore, our findings suggest that in the transition from a fermentative to a respiratory metabolism, the diauxic shift represents the stage where major structural and functional reorganizations in mitochondrial metabolism occur. This metabolic transition, initiated at the mitochondria level, is then extended to the rest of the yeast cell.
- 17 March 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (13) , 7524-7535
Open AccessAbsolute yeast mitochondrial proteome quantification reveals trade-off between biosynthesis and energy generation during diauxic shift
Saccharomyces cerevisiae constitutes a popular eukaryal model for research on mitochondrial physiology. Being Crabtree-positive, this yeast has evolved the ability to ferment glucose to ethanol and respire ethanol once glucose is consumed. Its transition phase from fermentative to respiratory metabolism, known as the diauxic shift, is reflected by dramatic rearrangements of mitochondrial function and structure. To date, the metabolic adaptations that occur during the diauxic shift have not been fully characterized at the organelle level. In this study, the absolute proteome of mitochondria was quantified alongside precise parametrization of biophysical properties associated with the mitochondrial network using state-of-the-art optical-imaging techniques. This allowed the determination of absolute protein abundances at a subcellular level. By tracking the transformation of mitochondrial mass and volume, alongside changes in the absolute mitochondrial proteome allocation, we could quantify how mitochondria balance their dual role as a biosynthetic hub as well as a center for cellular respiration. Furthermore, our findings suggest that in the transition from a fermentative to a respiratory metabolism, the diauxic shift represents the stage where major structural and functional reorganizations in mitochondrial metabolism occur. This metabolic transition, initiated at the mitochondria level, is then extended to the rest of the yeast cell.
- 16 January 2019
- Published by Springer Nature in Nature
- Vol. 565 (7739) , 294
Define working culture, don’t leave it to chance
- 16 January 2019
- Published by Springer Nature in Nature
- Vol. 565 (7739) , 294
Define working culture, don’t leave it to chance
- 1 January 2017
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1862 (1) , 25-38
Cell biology, physiology and enzymology of phosphatidylserine decarboxylase
- 1 January 2017
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1862 (1) , 25-38
Cell biology, physiology and enzymology of phosphatidylserine decarboxylase